"This is a transformational event for Addex which will enable us to advance our portfolio of allosteric modulator drug candidates through important value inflection points, including completing Phase 3 registration studies for dipraglurant," said Tim Dyer, CEO of Addex
Find an actor

MedTech Investing Europe 2018 (MTi)24.04.2018

The 26th MedTech Investing Europe Conference will be held on 24 and 25 April 2018 at the Royal Savoy Hotel in...

Retraites Populaires and Biopôle SA launch the first life sciences incubator in Canton of Vaud

9,100 m2 building, funded and constructed by Retraites Populaires on the site of Biopôle, a leading Swiss life...
Print this page Download this page (PDF) Recommend this page to a friend

Contact us

BioAlps Association
Ch. du Pré-Fleuri 3
CH - 1228 Plan-les Ouates
+41 22 304 40 40
+41 22 304 40 70

Subscribe to our newsletter

Find us on LinkedIn